Seminars in Hematology
Volume 45, Supplement 1 , Pages S25-S30, April 2008

Monitoring Inhibitor Patients With the Right Assays

  • Trevor W. Barrowcliffe

      Affiliations

    • Corresponding Author InformationAddress correspondence to Trevor W. Barrowcliffe, MA, PhD, 3 Boulby Bank, Whitby, Y022 4AN, UK.

Formerly of the National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Trevor Barrowcliffe has worked as a consultant for Novo Nordisk, on topics unrelated to the subject of this article.

PII: S0037-1963(08)00042-5

doi:10.1053/j.seminhematol.2008.03.002

Seminars in Hematology
Volume 45, Supplement 1 , Pages S25-S30, April 2008

Article Tools

* Image Usage & Resolution